COVID-19 Response: Local Logistics     National Effort

Wrightia Tinctoria Leaf Extracts to Treat Cancer

You are here

COVID-19 Response: Local Logistics     National Effort

The Novel Technology:

 
The invention discloses extracts having potential anticancer activity and the process of preparing extracts from the plant – Wrightia tinctoria. The anticancer activity of the extract shows maximum cytotoxicity against skin cancer as well as substantial cytotoxicity towards cervical and lung cancer cell lines.
 
Applications:
  • To induce apoptosis in cancer cells (particularly skin, cervical and lung cancer)
Advantages:
  • Targets only cancer cells (no cell death in normal cells) and extract can be used as safe and natural chemotherapeutic agent
  • Helps in reducing cost of chemotherapy
  • Anticancer compounds from extract may be identified further from Wrightia tinctoria leaf extract to identify active ingredient and for formulation of specific drug molecule
Business Model:
 
Early-stage technology demonstrating anticancer properties in leaf extract of Wrightia tinctoria. Looking for potential licensee(s) for taking the technology to next stage. 
 
Principal Investigator(s): Dr. Ruby John Anto, RGCB
 
Invention ID: CMP-010
 
IP Status: Patent Pending
 
Jurisdictions: India (IN)
 
For more details, please write to: